Thyrocare draft IPO

MUMBAI: Diagnostic company Thyrocare Technologies Ltd said on Thursday it had filed draft red herring prospectus with the country’s market regulator for an initial public offering (IPO) of 10.7 million shares. Thyrocare said it plans to list on both the BSE and NSE exchanges.